Lunsford v. Sterilite of Ohio, L.L.C. (Slip Opinion)

2020 Ohio 4193, 165 N.E.3d 245, 162 Ohio St. 3d 231
CourtOhio Supreme Court
DecidedAugust 26, 2020
Docket2018-1431
StatusPublished
Cited by28 cases

This text of 2020 Ohio 4193 (Lunsford v. Sterilite of Ohio, L.L.C. (Slip Opinion)) is published on Counsel Stack Legal Research, covering Ohio Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Lunsford v. Sterilite of Ohio, L.L.C. (Slip Opinion), 2020 Ohio 4193, 165 N.E.3d 245, 162 Ohio St. 3d 231 (Ohio 2020).

Opinion

[Until this opinion appears in the Ohio Official Reports advance sheets, it may be cited as Lunsford v. Sterilite of Ohio, L.L.C., Slip Opinion No. 2020-Ohio-4193.]

NOTICE This slip opinion is subject to formal revision before it is published in an advance sheet of the Ohio Official Reports. Readers are requested to promptly notify the Reporter of Decisions, Supreme Court of Ohio, 65 South Front Street, Columbus, Ohio 43215, of any typographical or other formal errors in the opinion, in order that corrections may be made before the opinion is published.

SLIP OPINION NO. 2020-OHIO-4193 LUNSFORD ET AL., APPELLEES, v. STERILITE OF OHIO, L.L.C., ET AL, APPELLANTS. [Until this opinion appears in the Ohio Official Reports advance sheets, it may be cited as Lunsford v. Sterilite of Ohio, L.L.C., Slip Opinion No. 2020-Ohio-4193.] Torts—Employment law—Invasion of privacy—When an at-will employee consents, without objection, to the collection of the employee’s urine sample under the direct-observation method, the at-will employee has no cause of action for invasion of privacy—Court of appeals’ judgment reversed and common pleas court’s judgment reinstated. (No. 2018-1431—Submitted January 28, 2020—Decided August 26, 2020.) APPEAL from the Court of Appeals for Stark County, No. 2017CA00232, 2018-Ohio-3437. __________________ SUPREME COURT OF OHIO

KENNEDY, J. {¶ 1} In this discretionary appeal from a judgment of the Fifth District Court of Appeals, we consider whether an at-will employee has a cause of action for common-law invasion of privacy as a result of his or her private employer’s implementation of a workplace substance-abuse policy requiring the employee to submit a urine sample for drug testing under the “direct-observation method.” For the reasons set forth below, we conclude that when an at-will employee consents, without objection, to the collection of his or her urine sample under the direct- observation method, the at-will employee has no cause of action for common-law invasion of privacy. Therefore, we reverse the judgment of the court of appeals and reinstate the judgment of the trial court. FACTS AND PROCEDURAL HISTORY {¶ 2} The complaint alleges that appellees Adam Keim and Laura Williamson are former at-will employees of appellant, Sterilite of Ohio, L.L.C. Appellees Donna L. Lunsford and Peter D. Griffiths are current at-will employees of Sterilite. {¶ 3} Sterilite, a private company, has a workplace substance-abuse policy that applies to all its employees, and compliance with the policy is a condition of employment. The purpose of the policy is to “promote a healthy, safe and productive workplace for all employees.” The policy reserves to Sterilite the discretion to change the policy at any time. {¶ 4} The policy sets out three circumstances under which Sterilite may exercise its discretion to require an employee to submit to drug testing: while investigating a workplace accident or incident, when there is reasonable suspicion that an employee may be impaired by drugs or alcohol, and randomly at periodic intervals. The policy also provides that urinalysis will be used to test for an employee’s illegal use of drugs or improper use of prescription or over-the-counter drugs, but it is silent on how the urine sample will be collected.

2 January Term, 2020

{¶ 5} Under the policy, a supervisor informs an employee when and where he or she is to report for testing. If the employee does not produce a valid urine sample within two and a half hours, the employee will be considered to have refused to take the test. An employee who refuses to take the test is subject to immediate termination. An employee whose urine sample tests positive for illegal drugs or prohibited use of prescription or over-the-counter drugs is subject to disciplinary action, up to and including termination. {¶ 6} Appellant U.S. Healthworks Medical Group of Ohio, Inc., administers Sterilite’s workplace drug-testing program. To facilitate drug testing under the policy, Sterilite designated a restroom to be used exclusively for the collection of urine samples. According to appellees’ complaint, U.S. Healthworks began collecting urine samples for drug testing by the “direct-observation method” in October 2016. Under that method, a same-sex monitor was required to accompany the employee to the restroom to visually observe the employee produce the urine sample. {¶ 7} Lunsford, Williamson, and Griffiths were selected by Sterilite for random drug testing on October 4 and 12 and November 8, 2016, respectively. Keim was asked to submit to drug testing based on the policy’s reasonable- suspicion-of-impairment provision on October 9, 2016. When appellees were instructed by their respective supervisors to report to the restroom designated by Sterilite for drug testing, each complied. {¶ 8} At the beginning of the testing process, each appellee executed a statement titled “Consent and Release” (“consent form”) provided by U.S. Healthworks. The consent form provided:

I hereby give my consent to and authorize U.S. Healthworks staff and its designated laboratory to perform any testing necessary to determine the presence and/or level of drugs in my body on behalf

3 SUPREME COURT OF OHIO

of my * * * current employer, whose name I entered above. I further give my consent for U.S. Healthworks to release any and all results to the aforementioned employer. I agree to hold harmless all U.S. Healthworks employees, physicians, and agents involved in the performance of the testing, from any action that may arise from the disclosure of such test results to the aforementioned employer * * *.

{¶ 9} Appellees did not know at the time they executed the consent form that his or her urine sample would be collected under the direct-observation method. None of the appellees had previously submitted a urine sample under the direct observation-method. Appellees were notified that the direct-observation method would be used when they reported to the restroom designated exclusively for urine collection. {¶ 10} Appellees each proceeded with the drug test under the direct- observation method without objection. Lunsford and Griffiths were each able to produce a valid urine sample. Keim and Williamson alleged in the complaint that they each made “good faith efforts” to produce a valid urine sample but were unable to do so within two and a half hours. Sterilite terminated Keim’s and Williamson’s employment pursuant to the policy. {¶ 11} Appellees filed in the Stark County Court of Common Pleas an eight-count complaint against appellants on December 22, 2016. At issue here is Count One of appellees’ complaint, which alleged that Sterilite and U.S. Healthworks invaded appellees’ privacy by requiring them to submit their urine samples under the direct-observation method. Appellees incorporated the policy into their complaint. {¶ 12} Appellees argued that Ohio law recognizes an individual’s right to privacy and to freedom from unreasonable invasion of one’s privacy. Appellees contended that because the direct-observation method is so “highly offensive to a

4 January Term, 2020

person of ordinary sensibilities,” Ohio’s courts should balance the intrusion of the direct-observation method against the employer’s legitimate business interests in conducting drug testing by that method. And if the intrusion outweighs the employer’s interests in conducting drug testing by that method, then the employer should be liable for invasion of privacy.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

State ex rel. Allah-U-Akbar v. Schroeder
2025 Ohio 5003 (Ohio Supreme Court, 2025)
Hill v. Hikel
2025 Ohio 2161 (Ohio Court of Appeals, 2025)
5812 Invest. Group, L.L.C. v. Columbus
2024 Ohio 5930 (Ohio Court of Appeals, 2024)
Thomas Merck v. Walmart, Inc.
114 F.4th 762 (Sixth Circuit, 2024)
Tchankpa v. Gauer
2024 Ohio 225 (Ohio Court of Appeals, 2024)
Dayton v. Siff
2023 Ohio 4685 (Ohio Court of Appeals, 2023)
Feasby v. Logan
2023 Ohio 4478 (Ohio Court of Appeals, 2023)
Meolatate v. Ohio State Univ.
2023 Ohio 3805 (Ohio Court of Appeals, 2023)
Childs v. Kroger
2023 Ohio 2034 (Ohio Court of Appeals, 2023)
State ex rel. US Bank Trust, Natl. Assn. v. Cuyahoga Cty.
2023 Ohio 1063 (Ohio Supreme Court, 2023)
Morlatt v. Johnson
2022 Ohio 4155 (Ohio Court of Appeals, 2022)
Woods v. Sharkin
2022 Ohio 1949 (Ohio Court of Appeals, 2022)
State ex rel. Parker v. Black
2022 Ohio 1730 (Ohio Supreme Court, 2022)
Brown v. Fukuvi USA Inc.
2022 Ohio 1608 (Ohio Court of Appeals, 2022)
State ex rel. Guthrie v. Fender (Slip Opinion)
2022 Ohio 767 (Ohio Supreme Court, 2022)
Buckeye Inst. v. Kilgore
2021 Ohio 4196 (Ohio Court of Appeals, 2021)

Cite This Page — Counsel Stack

Bluebook (online)
2020 Ohio 4193, 165 N.E.3d 245, 162 Ohio St. 3d 231, Counsel Stack Legal Research, https://law.counselstack.com/opinion/lunsford-v-sterilite-of-ohio-llc-slip-opinion-ohio-2020.